Effect of Metformin on Viability, Morphology, and Ultrastructure of Mouse Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells and Balb/3T3 Embryonic Fibroblast Cell Line
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Metformin on Viability, Morphology, and Ultrastructure of Mouse Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells and Balb/3T3 Embryonic Fibroblast Cell Line
Authors
Keywords
-
Journal
Biomed Research International
Volume 2015, Issue -, Pages 1-14
Publisher
Hindawi Limited
Online
2015-05-01
DOI
10.1155/2015/769402
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice
- (2016) Vladimir N. Anisimov et al. Aging-US
- The influence of static magnetic fields on canine and equine mesenchymal stem cells derived from adipose tissue
- (2014) Monika Marędziak et al. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
- Retraction Note to: Stimulus-triggered fate conversion of somatic cells into pluripotency
- (2014) Haruko Obokata et al. NATURE
- Application of bone marrow and adipose-derived mesenchymal stem cells for testing the biocompatibility of metal-based biomaterials functionalized with ascorbic acid
- (2013) Krzysztof Marycz et al. Biomedical Materials
- Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells
- (2013) Emelie Karnevi et al. BMC CANCER
- Oct4 and Sox2 overexpression improves the proliferation and differentiation of bone mesenchymal stem cells in Xiaomeishan porcine
- (2013) Y.X. Fan et al. GENETICS AND MOLECULAR RESEARCH
- The morphology, proliferation rate, and population doubling time factor of adipose-derived mesenchymal stem cells cultured on to non-aqueous SiO2, TiO2, and hybrid sol-gel-derived oxide coatings
- (2013) Krzysztof Marycz et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing
- (2013) J. Jeyabalan et al. OSTEOPOROSIS INTERNATIONAL
- Metformin: an old but still the best treatment for type 2 diabetes
- (2013) Lilian Beatriz Aguayo Rojas et al. Diabetology & Metabolic Syndrome
- Modelling and optimization of chromiumIII biosorption on soybean meal
- (2013) Anna Witek-Krowiak et al. Open Chemistry
- In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma
- (2012) Qingqiong Luo et al. BMC CANCER
- Rejuvenating regeneration: Metformin activates endogenous adult stem cells
- (2012) JAVIER MENENDEZ et al. CELL CYCLE
- Igf2-H19, an imprinted tandem gene, is an important regulator of embryonic development, a guardian of proliferation of adult pluripotent stem cells, a regulator of longevity, and a ‘passkey’ to cancerogenesis
- (2012) Mariusz Z. Ratajczak FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
- (2012) Hsiao-Ping Chen et al. GUT
- Multinucleated giant cells from fibroblast cultures
- (2011) Dolly J. Holt et al. BIOMATERIALS
- Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
- (2011) Irina N. Alimova et al. CELL CYCLE
- Metformin induces unique biological and molecular responses in triple negative breast cancer cells
- (2011) Bolin Liu et al. CELL CYCLE
- Cellular and molecular mechanisms of metformin: an overview
- (2011) Benoit Viollet et al. CLINICAL SCIENCE
- An application of scanning electron microscopy combined with roentgen microanalysis (SEM-EDS) in canine urolithiasis
- (2011) K. Kalinski et al. Microscopy
- Metformin and cancer: new applications for an old drug
- (2011) Taxiarchis V. Kourelis et al. MEDICAL ONCOLOGY
- Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153
- (2011) N. WU et al. NEOPLASMA
- Evaluation of the use of human Mesenchymal Stem Cells for acute toxicity tests
- (2011) M. Scanu et al. TOXICOLOGY IN VITRO
- Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery
- (2010) Christopher D. Porada et al. ADVANCED DRUG DELIVERY REVIEWS
- Development of Calorie Restriction Mimetics as Therapeutics for Obesity, Diabetes, Inflammatory and Neurodegenerative Diseases
- (2010) Takuya Chiba et al. CURRENT GENOMICS
- Impaired mesenchymal stem cell differentiation and osteoclastogenesis in mice deficient for Igf2-P2 transcripts
- (2010) S. N. Hardouin et al. DEVELOPMENT
- Diabetes and Cancer: A consensus report
- (2010) E. Giovannucci et al. DIABETES CARE
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
- (2010) Marc Foretz et al. JOURNAL OF CLINICAL INVESTIGATION
- Mesenchymal Stem Cells: Flip Side of the Coin
- (2009) Pravin J. Mishra et al. CANCER RESEARCH
- Metformin induces glucose uptake in human preadipocyte-derived adipocytes from various fat depots
- (2009) M. Fischer et al. DIABETES OBESITY & METABOLISM
- Effect of metformin on bone marrow progenitor cell differentiation: In vivo and in vitro studies
- (2009) M Silvina Molinuevo et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Induction of Stem Cell Gene Expression in Adult Human Fibroblasts without Transgenes
- (2009) Raymond L. Page et al. Cloning Stem Cells
- In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
- (2008) Walter H. Gotlieb et al. GYNECOLOGIC ONCOLOGY
- Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cells
- (2008) Ying Gao et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Differentiation of Bone Marrow Mesenchymal Stem Cells into the Smooth Muscle Lineage by Blocking ERK/MAPK Signaling Pathway
- (2008) Kenichi Tamama et al. STEM CELLS AND DEVELOPMENT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now